このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Advanced Health Intelligence マネジメント

マネジメント基準チェック /24

Advanced Health Intelligence'sの CEO はScott Montgomeryで、 Dec2022年に任命され、の在任期間は 1.33年です。の年間総報酬はA$ 364.94Kで、 58.3%給与と41.7%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の1.76%を直接所有しており、その価値はA$ 396.97K 。経営陣と取締役会の平均在任期間はそれぞれ5年と2.2年です。

主要情報

Scott Montgomery

最高経営責任者

AU$364.9k

報酬総額

CEO給与比率	58.3%
CEO在任期間	1.3yrs
CEOの所有権	1.8%
経営陣の平均在職期間	5yrs
取締役会の平均在任期間	2.2yrs

経営陣の近況

Recent updates

CEO報酬分析

Advanced Health Intelligence の収益と比較して、Scott Montgomery の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Dec 31 2023	n/a	n/a	-AU$17m
Sep 30 2023	n/a	n/a	-AU$15m
Jun 30 2023	AU$365k	AU$213k	-AU$13m

報酬と市場: Scottの総報酬 ($USD 239.70K ) は、 Australian市場 ($USD 300.74K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Scottの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Scott Montgomery (41 yo)

1.3yrs

在職期間

AU$364,938

報酬

Mr. Scott Montgomery serves as Chief Executive Officer & Executive Director of Advanced Health Intelligence Ltd. (formerly known as Advanced Human Imaging Limited) since December 1, 2022. Mr Montgomery co-...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Scott Montgomery	CEO & Executive Director	1.3yrs	AU$364.94k	1.76% A$ 397.0k
Katherine Iscoe	Co-Founder & Executive Director	10.3yrs	AU$284.24k	13.96% A$ 3.2m
Simon Durack	CFO & Company Secretary	2.1yrs	AU$277.31k	データなし
Vlado Bosanac	Founder & Head of Strategy	11.3yrs	AU$6.78m	0% A$ 0
Terence Stupple	Chief Technology Officer	8.3yrs	データなし	1.73% A$ 391.0k
Riaan Conradie	Chief Science Officer	no data	データなし	データなし
Anita Swan	Marketing Director	8yrs	データなし	データなし
Nadine Amesz	Head of Operations	no data	データなし	データなし
Kevin Baum	Chief Product Officer	1.3yrs	データなし	データなし
Dylan Garnett	Chief Innovation Officer	1.3yrs	データなし	データなし

5.0yrs

平均在職期間

47yo

平均年齢

経験豊富な経営陣: AHIの経営陣は経験豊富で経験豊富です（平均在職期間は5年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Scott Montgomery	CEO & Executive Director	1.3yrs	AU$364.94k	1.76% A$ 397.0k
Katherine Iscoe	Co-Founder & Executive Director	2.2yrs	AU$284.24k	13.96% A$ 3.2m
Peter Goldstein	Non-Executive Independent Director	1.8yrs	AU$53.43k	データなし
Michael Melby	Independent Non-Executive Director	6.5yrs	AU$36.00k	データなし
Nicholas John Prosser	Chairman	6yrs	AU$41.31k	2.96% A$ 668.4k
Koon Poh Low	Independent Non-Executive Director	3.8yrs	AU$36.00k	0.12% A$ 27.6k
Soak Yee	Independent Non-Executive Director	1.3yrs	AU$18.00k	データなし

2.2yrs

平均在職期間

48yo

平均年齢

経験豊富なボード: AHIの取締役会は経験豊富ではない ( 2.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Advanced Health Intelligence マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Recent updates

Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.32

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.61

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

CEO報酬分析

CEO（最高経営責任者

マネジメント基準チェック /24